BUSINESS
Coronavirus impact | Online B2B platform Medikabazaar sees massive surge in enquiries
The company, however, is facing challenges in delivering medical supplies to hospitals.
BUSINESS
Coronavirus lockdown | Govt's fresh guidelines to help ease operations of pharma companies, medical device makers
Manufacturing units of essential goods, including drugs, pharmaceuticals, medical devices, medical oxygen and their raw material and intermediates will be allowed to function subject to social distancing norms specified by the government.
BUSINESS
ICMR pitches for pooling samples for COVID-19 testing in areas with less than 2% positive cases
"It has been demonstrated that performing real-time PCR for COVID-19 by pooling 5 samples of TS/NS is feasible when the prevalence rates of infection are low," the council's advisory says.
BUSINESS
India is scaling up health infrastructure, has 1 lakh beds for COVID-19 patients, says PM Modi
According to the world's experience of tackling COVID-19, 1500-1600 beds are needed when cases reach 10,000, the prime minister said in his speech.
BUSINESS
Coronavirus lockdown | No medicine shortages anticipated, India has 3 months inventory: AIOCD
As production and transport ramps up, the stock level can only go up and continue to stabilize, AIOCD said.
BUSINESS
USFDA asks companies to remove ranitidine products; will Indian regulator review its stand?
The USFDA is investigating presence N-Nitrosodimethylamine, a probable cancer causing impurity in ranitidine products.
BUSINESS
India has enough HCQ capacity to serve demand, clinical trial outcome is crucial
Despite limited clinical evidence, HCQ is now used by many countries for treating COVID-19 patients.
BUSINESS
Cadila Healthcare says can ramp up HCQ capacity, vaccine to enter human testing in Q2FY21
The company's MD Sharvil Patel said Cadila doesn't depend on imports for the drug, implying that it makes key starting material and intermediates that are typically imported from China for most other drugs
BUSINESS
Free COVID-19 tests: Private labs cry foul, say need government support
Sources told Moneycontrol that private diagnostic labs, who have asked for govt help, will be collectively filing an appeal against the apex court's interim order.
BUSINESS
Coronavirus pandemic: OPPI says pharma supply chain disruption easing, companies have stock for 2-3 months
Manufacturing units are slowly coming back to normalcy.
BUSINESS
Indian Immunologicals partners with Griffith University to develop COVID-19 vaccine
IIL becomes the fourth Indian vaccine maker to announce vaccine development against COVID-19.
BUSINESS
India excludes hydroxychloroquine from export list despite Trump’s warning, eases ban on certain essential drugs
India on March 3 banned export of all the above drugs fearing shortages of essential drugs due supply chain disruption from China. However many countries expressed concern about export restrictions.
BUSINESS
Coronavirus pandemic: 'Pool testing' for COVID-19 may benefit India as US study proves test feasibility, efficacy
A pooled testing method involves putting multiple swab samples in a test tube and testing them using a single RT-PCR test.
BUSINESS
Intranasal COVID-19 vaccine: Bharat Biotech ties up with FluGen, UW-Madison virologists
CoroFlu could be in human clinical trials by fall (September-December) of 2020, Bharat Biotech statement said.
BUSINESS
Coronavirus pandemic: COVID-19 test kit maker Mylab gets funding from Adar Poonawalla, Abhijit Pawar
The Pune-based company to deploy the funds to scale up operations and quicken delivery of testing kits for COVID-19.
BUSINESS
Coronavirus pandemic: This is how India is trying to overcome ventilator shortage
Experts say, if COVID-19 cases surge in days ahead, we may struggle as nearly 3 percent of COVID-19 patients would require ventilators.
BUSINESS
SC urges media not to disseminate unverified news that causes panic
"We do not intend to interfere with the free discussion about the pandemic, but direct the media refer to and publish the official version about the developments," the apex court order said.
BUSINESS
Coronavirus pandemic | Abbott says it has plans to bring COVID-19 tests to the world
Abbott announced early this week that it had received USFDA's Emergency Use Authorisation (EUA) for its rapid, portable, point-of-care molecular test for the detection of COVID-19.
BUSINESS
Explained | What makes hydroxychloroquine popular? Is it really effective against coronavirus?
Trump calling hydroxychloroquine and azithromycin as the ‘biggest game changer’ in the history of medicine has brought the drug to the centre stage
BUSINESS
USFDA classifies Sun Pharma's Halol manufacturing site for official action, may put all new approvals on hold
The OAI status implies that the USFDA may put all new approvals from the Halol facility on hold till the outstanding corrective actions are completed.
BUSINESS
Pharma wrap: Telemedicine guidelines to help standardise care, give fillip to online consulting apps
Telemedicine isn't just confined to a phone call, but covers a gamut of applications such as video, chat platforms like WhatsApp, Facebook Messenger etc., or Mobile App or internet based digital platforms for telemedicine or data transmission systems like Skype, email and fax.
BUSINESS
Abbott gets approval to launch 5-minute COVID-19 test for use almost anywhere
Abbott's testing kit will be major game changer, as currently even in advanced countries like US and Europe, it is taking 24-48 hours to get laboratory test result.
BUSINESS
COVID-19 impact | Private hospitals hit hard, steep drop in OPD footfalls
Even India's largest healthcare chains like Apollo Hospitals has warned about the "total crash of the system" if government doesn't step in .
BUSINESS
Coronavirus: Laurus Labs to supply Hydroxychloroquine for clinical trials in the US
The company has received an approval from the US Food & Drug Administration (USFDA) to market Hydroxychloroquine Sulphate tablets
